Literature DB >> 2177080

Establishment and characterization of a primitive neuroectodermal tumor of bone continuous cell line (LAP-35).

G P Bagnara1, M Serra, M Giovannini, M Badiali, M Stella, A Montaldi, D Granchi, P Paolucci, P Rocchi, A Pession.   

Abstract

A continuous tumor cell line (LAP-35) was established from a primitive neuroectodermal tumor of bone from the right tibia of a 12-year-old female. The neural character of the cell line was documented by the spontaneous growth of neurites and by the presence of several neural markers, including neuron-specific enolase (NSE), S-100 protein, neurofilaments, chromogranin A, synaptophysin and positivity to monoclonal antibodies UJ127.11, UJ13A, UJ181.4. Cell-sorter analysis showed a high expression of nerve growth factor receptor (NGFr) and major histocompatibility complex class I-related molecules. A unique cytogenetic profile was observed, including a reciprocal chromosomal translocation (rct) 11:22 (q24;q12), typically associated with Ewing's sarcoma and neuroepithelioma, and deletion of the short arm of chromosome 1 (lp-), otherwise a feature of neuroblastoma. N-myc proto-oncogene was neither amplified nor expressed, whereas the expression of c-myc was documented by northern blot analysis. These features distinguish this new cell line from previously reported neuroectodermal cell lines, identifying LAP-35 as a unique model of a group of neural bone tumors that share characteristics of neuroblastoma as well as neuroepithelioma.

Entities:  

Mesh:

Year:  1990        PMID: 2177080     DOI: 10.1002/stem.5530080644

Source DB:  PubMed          Journal:  Int J Cell Cloning        ISSN: 0737-1454


  8 in total

1.  EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.

Authors:  M Giovannini; J A Biegel; M Serra; J Y Wang; Y H Wei; L Nycum; B S Emanuel; G A Evans
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

2.  Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response.

Authors:  Camilla Cristalli; Maria Cristina Manara; Sergio Valente; Evelin Pellegrini; Alberto Bavelloni; Alessandra De Feo; William Blalock; Elisabetta Di Bello; David Piñeyro; Angelika Merkel; Manel Esteller; Oscar M Tirado; Antonello Mai; Katia Scotlandi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

3.  Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors.

Authors:  M Giovannini; L Selleri; J A Biegel; K Scotlandi; B S Emanuel; G A Evans
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

4.  Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.

Authors:  Cecilia Garofalo; Mariantonietta Capristo; Maria Cristina Manara; Caterina Mancarella; Lorena Landuzzi; Antonino Belfiore; Pier-Luigi Lollini; Piero Picci; Katia Scotlandi
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy.

Authors:  Rosa Simona Pinca; Maria Cristina Manara; Valentina Chiadini; Piero Picci; Cinzia Zucchini; Katia Scotlandi
Journal:  Oncol Rep       Date:  2017-01-20       Impact factor: 3.906

6.  Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma.

Authors:  Francesca Chiarini; Francesca Paganelli; Tommaso Balestra; Cristina Capanni; Antonietta Fazio; Maria Cristina Manara; Lorena Landuzzi; Stefania Petrini; Camilla Evangelisti; Pier-Luigi Lollini; Alberto M Martelli; Giovanna Lattanzi; Katia Scotlandi
Journal:  Cell Death Dis       Date:  2022-04-14       Impact factor: 9.685

7.  An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Authors:  Clara Guerzoni; Stefano Amatori; Luca Giorgi; Maria Cristina Manara; Lorena Landuzzi; Pier-Luigi Lollini; Aurora Tassoni; Mauro Balducci; Marco Manfrini; Loredana Pratelli; Massimo Serra; Piero Picci; Mauro Magnani; Vieri Fusi; Mirco Fanelli; Katia Scotlandi
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

8.  Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9.

Authors:  Marco Fidaleo; Francesca Svetoni; Elisabetta Volpe; Belén Miñana; Daniela Caporossi; Maria Paola Paronetto
Journal:  Oncotarget       Date:  2015-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.